Targeting NSD2-mediated SRC-3 liquid–liquid phase separation sensitizes bortezomib treatment in multiple myeloma

Jing Liu(Tianjin Medical University), Zhiqiang Liu(Tianjin Medical University)
Nature Communications
February 15, 2021
Cited by 76


Related Papers